united kingdomen
From deep value to ‘value with a future’

From deep value to ‘value with a future’

28-04-2021 | Quarterly outlook

As the global economy continues to recover, our positive stance on global equity markets remains well underpinned. Both our developed (DM) and emerging markets (EM) teams have remained positive on their respective equity segments.

  • Michiel  Plakman
    Michiel
    Plakman
    Portfolio Manager Robeco Global Stars Equities
  • Wim-Hein  Pals
    Wim-Hein
    Pals
    Head of Emerging Markets team

Speed read

  • Our stance remains positive for both EM and DM
  • Value still has potential to perform, but investors likely to be more selective 
  • North Asia remains a bright spot and we turned more positive on US equities

Parts of the world are still wrangling with Covid-19 and lockdowns, and sometime in the second quarter of 2021, the market is likely to start anticipating the dreaded t-word (‘t’ for ‘tapering’). Yet countries are learning to co-exist with a pandemic, the US has sprung on us a USD 1.9 trillion stimulus package, and the Biden administration is working on USD 2.3 trillion in infrastructure investments. 

While the fiscal bonanza will impact the US first, the rest of the world will also benefit from its repercussions for global activity. Let’s not forget that the strong recovery expected in global trade is one of the reasons why the International Monetary Fund has lifted its 2021 China GDP growth estimate to an impressive 8.4%.

Clearly, a sizzling economy means higher inflation, but we are still far from levels that would reverse the course of the economic recovery. We are, actually, in the sweet spot for equity markets, as these generally benefit from inflation rising from low levels: historically, the S&P 500 Index has shown outperformance most frequently when CPI was between 1% and 3%.

Both our DM and EM teams have remained positive on their respective equity markets. The only factor that we downgraded, from positive to neutral, is the sentiment factor in EM. We have seen unprecedented investment flows into EM of more than USD 120 billion since October 2020, and we expect inflows to continue but at a slower pace.

Stay informed on our latest insights with monthly mail updates
Stay informed on our latest insights with monthly mail updates
Subscribe

Focus on ‘value with a future’

We expect further rotation from the Covid-beneficiary and Covid-defensive stocks to those that will benefit from the economic normalization. This means that value has further outperformance ahead – as long as the economic outlook continues to improve. However, we expect an increased degree of selectivity among investors in their choice of stocks.

Value has further outperformance ahead – as long as the economic outlook continues to improve

Investors will start to look for stocks with the ability to deliver on their perceived value, showing better earnings potential in a normalization of the macroeconomic backdrop. Therefore, after the first wave of value investing boosted all cheap stocks, we expect the second wave to focus on what we call ‘value with a future’, i.e. companies with inexpensive valuations that do not discount their sustained earnings growth ahead.

Our largest overweight across portfolios remains North Asia, although we have taken some profit in China, where we expect market momentum to slow down. Credit growth in the country has peaked, and this is likely to lead earnings to peak. Moreover, around 40% of the weight of the MSCI China Index is in internet-related stocks. This affects the index in the rotation away from expensive and often loss-making digital stocks.

That said, the main change from a country standpoint in our Global Equity portfolios occurred in DM, as we have added to US equities at the expense of Europe. The US is more advanced in fighting the pandemic, and has significantly stepped up fiscal stimulus. We believe that a recovery in the US will be much stronger than in Europe for the foreseeable future, and that US equities will benefit.

Read the full Fundamental Outlook

Disclaimer

This report is not available for users from countries where the offering of foreign financial services is not permitted, such as US Persons.

Your details are not shared with third parties. This information is exclusively intended for professional investors. All requests are checked.

Logo

Disclaimer

Please read this important information before proceeding further. It contains legal and regulatory notices relevant to the information contained on this website.

The information contained in the Website is NOT FOR RETAIL CLIENTS - The information contained in the Website is solely intended for professional investors, defined as investors which (1) qualify as professional clients within the meaning of the Markets in Financial Instruments Directive (MiFID), (2) have requested to be treated as professional clients within the meaning of the MiFID or (3) are authorized to receive such information under any other applicable laws. The value of the investments may fluctuate. Past performance is no guarantee of future results. Investors may not get back the amount originally invested. Neither Robeco Institutional Asset Management B.V. nor any of its affiliates guarantees the performance or the future returns of any investments. If the currency in which the past performance is displayed differs from the currency of the country in which you reside, then you should be aware that due to exchange rate fluctuations the performance shown may increase or decrease if converted into your local currency.

In the UK, Robeco Institutional Asset Management B.V. (“ROBECO”) only markets its funds to institutional clients and professional investors. Private investors seeking information about ROBECO should visit our corporate website www.robeco.com or contact their financial adviser. ROBECO will not be liable for any damages or losses suffered by private investors accessing these areas.

In the UK, ROBECO Funds has marketing approval for the funds listed on this website, all of which are UCITS funds. ROBECO is authorized by the AFM and subject to limited regulation by the Financial Conduct Authority. Details about the extent of our regulation by the Financial Conduct Authority are available from us on request.

Many of the protections provided by the United Kingdom regulatory framework may not apply to investments in ROBECO Funds, including access to the Financial Services Compensation Scheme and the Financial Ombudsman Service. No representation, warranty or undertaking is given as to the accuracy or completeness of the information on this website.

If you are not an institutional client or professional investor you should therefore not proceed. By proceeding please note that we will be treating you as a professional client for regulatory purposes and you agree to be bound by our terms and conditions.

If you do not accept these terms and conditions, as well as the terms of use of the website, please do not continue to use or access any pages on this website.

I Disagree